| Pharmaceutical Information |
| Drug Name |
Halothane |
| Drug ID |
BADD_D01057 |
| Description |
A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. nitrous oxide is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) |
| Indications and Usage |
For the induction and maintenance of general anesthesia |
| Marketing Status |
approved; vet_approved |
| ATC Code |
N01AB01 |
| DrugBank ID |
DB01159
|
| KEGG ID |
D00542
|
| MeSH ID |
D006221
|
| PubChem ID |
3562
|
| TTD Drug ID |
D0D8VE
|
| NDC Product Code |
Not Available |
| UNII |
UQT9G45D1P
|
| Synonyms |
Halothane | 1,1,1-Trifluoro-2-Chloro-2-Bromoethane | Ftorotan | Narcotan | Fluothane |
|
| Chemical Information |
| Molecular Formula |
F3CCHBrCl |
| CAS Registry Number |
151-67-7 |
| SMILES |
C(C(F)(F)F)(Cl)Br |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
